System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Rudolf M Huber is an expert in Pulmonology at LMU Klinikum (Germany). As of April 2026, ScienceLeadR ranks Rudolf M Huber in the top 1% of experts worldwide for Lung Neoplasms and Thoracic Neoplasms. Rudolf M Huber has authored 334 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 925 (community average: 125). How the SLR is computed.

LeadR Profile

Rudolf M Huber LMU Klinikum Germany
925 ScienceLeadR Reputation 925

Unlock

Register Login
Network Map

Pulmonology

Subspecialties: Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1990 - 2026
Source: PubMed

Ludwig-Maximilians-Universität München

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 334

Citations

Citations: 16 387 1st author: 34 Last author: 88 Unique author: 9

Main journals

J Thorac Oncol 28
Pneumologie 18
Eur Respir J 17
J Clin Oncol 17
Onkologie 14

Best Journals

J Clin Oncol 2
Lancet Oncol 2
Eur Respir J 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Reply regarding the European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.
PMID 41991213 — lung, respiration, neoplasms, lung neoplasms, therapeutics, surgeons		Eur Respir J20260
A Game-Changing 20 Years: Progress and Future Directions in Lung Cancer Screening.
PMID 41651571 — mortality, lung, neoplasms, biomarkers, lung neoplasms		J Thorac Oncol20260
A Response to the Letter to the Editor: "Quality Performance Indicators for Lung Cancer Screening: Towards the Next Levels?"
PMID 40484491 — lung, neoplasms, lung neoplasms		J Thorac Oncol20250
Safety and Sample Adequacy for Comprehensive Biomarker Testing of Bronchoscopic Biopsies: An American Association of Bronchology and Interventional Pulmonology and International Association for the Study of Lung Cancer Clinical Practice Guideline.
PMID 40419141 — pulmonary medicine, research design, lung, safety, neoplasms, biopsy, biomarkers, lung neoplasms, wounds and injuries		J Thorac Oncol20250
Response to the Letters to the Editor by Jing Peng and Colleagues and by Lauren C Leiman Regarding the Manuscript "Terminology Issues in Screening and Early Detection of Lung Cancer-International Association for the Study of Lung Cancer Early Detection and Screening Committee Expert Group Recommendations".
PMID 39794116 — lung, thoracic neoplasms, early detection of cancer, neoplasms, lung neoplasms		J Thorac Oncol20250

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1 Study Chair: 2

By phase:

Phase 1 2
Phase 2 2

By status:

Completed 3
Withdrawn 1

By type:

Interventional 4

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 2
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS